Similarly, ZBTB4 can transcriptionally inhibit specific protein transcription factors (Sp1, Sp3, and Sp4), thereby inhibiting the proliferation of prostate cancer cells and promoting cell apoptosis.20 Here, SP4 is linked to prostate carcinoma.